MRA Associates USA’s Elevance Health ELV Stock Holding History

MRA Associates USA’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-37	Closed	-$10.4K	–	126
2019 Q2	$10.4K	Buy	+37	New	+$10.1K	0.04%	106

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

MRA Associates USA's ELV Position: Q3 2019 in Review

MRA Associates USA sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 37 shares — an estimated $10.4K sold.

MRA Associates USA first reported a position in ELV in Q2 2019 and held it in 1 quarter. The position peaked at $10.4K in Q2 2019. 1,015 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

MRA Associates USA reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
MRA Associates USA sold 37 Elevance Health shares in Q3 2019, an estimated $10.4K.
MRA Associates USA first reported a position in Elevance Health in Q2 2019 and held it in 1 quarter.
MRA Associates USA's Elevance Health position peaked at $10.4K in Q2 2019.
1,015 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on MRA Associates USA's 13F filing for Q3 2019, filed 8 Nov 2019.